Comments
American tennis star Jimmy Connors on Friday urged the United States Food and Drug Administration (FDA) to consider approval for Hyderabad-based Bharat Biotech’s Covaxin.
“@CNN @FoxNews @US_FDA You always talk about Pfizer- J&J- Moderna vaccines — maybe a nod to #Covaxin - #ocgn - an opportunity to have an option - a choice- allow COVAXIN to get in the game— I’m no Dr.- but the others have had a chance- why not #COVAXIN !!! #Competition #lookitup,” Connors wrote in a tweet.
Covaxin has also been granted emergency-use listing (EUL) by the World Health Organization (WHO).
Also see: Covaxin trials on children show robust safety, says Bharat Biotech
Connors’ tweet comes amid a significant surge in Covid-19 cases in the US, driven primarily by the new Omicron variant of the coronavirus, as per reports.
Over a year after Covid-19 vaccine was rolled out in the country, new cases have surged to their highest level on record, more than doubled at over 2,65,000 per day on average, according to data by Johns Hopkins University.
With over 580,000 cases, it broke its own record for new daily coronavirus cases on Thursday, as per the New York Times database.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.